These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25957467)

  • 1. Circulating microRNAs for the prediction of metastasis in breast cancer patients diagnosed with early stage disease.
    Inns J; James V
    Breast; 2015 Aug; 24(4):364-9. PubMed ID: 25957467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non Coding RNA Molecules as Potential Biomarkers in Breast Cancer.
    De Leeneer K; Claes K
    Adv Exp Med Biol; 2015; 867():263-75. PubMed ID: 26530371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic and therapeutic application of microRNAs in breast cancer: Tissue and circulating microRNAs.
    Bahrami A; Aledavood A; Anvari K; Hassanian SM; Maftouh M; Yaghobzade A; Salarzaee O; ShahidSales S; Avan A
    J Cell Physiol; 2018 Feb; 233(2):774-786. PubMed ID: 28109133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating miRNAs revealed as surrogate molecular signatures for the early detection of breast cancer.
    Mishra S; Srivastava AK; Suman S; Kumar V; Shukla Y
    Cancer Lett; 2015 Dec; 369(1):67-75. PubMed ID: 26276721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosome-encapsulated microRNAs as circulating biomarkers for breast cancer.
    Joyce DP; Kerin MJ; Dwyer RM
    Int J Cancer; 2016 Oct; 139(7):1443-8. PubMed ID: 27170104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic breast cancer: the potential of miRNA for diagnosis and treatment monitoring.
    McGuire A; Brown JA; Kerin MJ
    Cancer Metastasis Rev; 2015 Mar; 34(1):145-55. PubMed ID: 25721950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell-free miRNAs as non-invasive biomarkers in breast cancer: Significance in early diagnosis and metastasis prediction.
    Kashyap D; Kaur H
    Life Sci; 2020 Apr; 246():117417. PubMed ID: 32044304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technology in MicroRNA Profiling: Circulating MicroRNAs as Noninvasive Cancer Biomarkers in Breast Cancer.
    Pimentel F; Bonilla P; Ravishankar YG; Contag A; Gopal N; LaCour S; Lee T; Niemz A
    J Lab Autom; 2015 Oct; 20(5):574-88. PubMed ID: 25524488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of Circulating MicroRNAs in Breast Cancer as Diagnostic and Therapeutic Efficacy Biomarkers.
    Aggarwal V; Priyanka K; Tuli HS
    Mol Diagn Ther; 2020 Apr; 24(2):153-173. PubMed ID: 32067191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating microRNAs: potential biomarkers for common malignancies.
    Khoury S; Tran N
    Biomark Med; 2015; 9(2):131-51. PubMed ID: 25689901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs as biomarkers for early breast cancer diagnosis, prognosis and therapy prediction.
    Nassar FJ; Nasr R; Talhouk R
    Pharmacol Ther; 2017 Apr; 172():34-49. PubMed ID: 27916656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring circulating micro-RNA in the neoadjuvant treatment of breast cancer.
    Casey MC; Sweeney KJ; Brown JA; Kerin MJ
    Int J Cancer; 2016 Jul; 139(1):12-22. PubMed ID: 26756433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot Study of Serum MicroRNA-21 as a Diagnostic and Prognostic Biomarker in Egyptian Breast Cancer Patients.
    Toraih EA; Mohammed EA; Farrag S; Ramsis N; Hosny S
    Mol Diagn Ther; 2015 Jun; 19(3):179-90. PubMed ID: 26063582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of microRNAs -29b-2, -155, -197 and -205 as diagnostic biomarkers in serum of breast cancer females.
    Shaker O; Maher M; Nassar Y; Morcos G; Gad Z
    Gene; 2015 Apr; 560(1):77-82. PubMed ID: 25644077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-125a-5p is a prognostic biomarker that targets HDAC4 to suppress breast tumorigenesis.
    Hsieh TH; Hsu CY; Tsai CF; Long CY; Chai CY; Hou MF; Lee JN; Wu DC; Wang SC; Tsai EM
    Oncotarget; 2015 Jan; 6(1):494-509. PubMed ID: 25504437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early Detection of Lung Cancer in Serum by a Panel of MicroRNA Biomarkers.
    Wang P; Yang D; Zhang H; Wei X; Ma T; Cheng Z; Hong Q; Hu J; Zhuo H; Song Y; Jia C; Jing F; Jin Q; Bai C; Mao H; Zhao J
    Clin Lung Cancer; 2015 Jul; 16(4):313-9.e1. PubMed ID: 25639977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Non-coding RNA as Biomarkers in Colorectal Cancer.
    Ferracin M; Lupini L; Mangolini A; Negrini M
    Adv Exp Med Biol; 2016; 937():171-81. PubMed ID: 27573900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Cancer Biomarkers: The Macro-revolution of the Micro-RNA.
    Montani F; Bianchi F
    EBioMedicine; 2016 Mar; 5():4-6. PubMed ID: 27077096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
    Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
    Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.